Research Final Update from Dr. Sleeper to develop gene therapy for Dilated Cardiomyopathy.
To date, 9 dogs have been screened for enrollment in this study, four dogs have undergone treatment (enrolled), one dog is scheduled for treatment (enrollment), one dog had a fatal arrhythmia while waiting for vector antibody titer results and three dogs have had vector antibody titers too high to safely treat. Data collection is therefore underway and as more dogs are treated interim statistical analysis will be performed to evaluate benefit or negative impact of treatment. We continue to advertise the clinical trial by various methods.
Mid-year 6 Research Update Dr. Sleeper to develop gene therapy for Dilated Cardiomyopathy.
